Articles tagged with Swine Flu
A study by the University of Washington found that Google Flu Trends is less accurate in estimating laboratory-confirmed influenza cases compared to CDC surveillance. The analysis revealed a 25% error margin during the 2003-04 flu season, with greatest deviations occurring during periods of high media attention or unexpected activity.
The article reviews HealthMap's H1N1 surveillance efforts, demonstrating the value of informal data in producing a comprehensive real-time global health picture. The analysis identified disparities in international public health systems, with countries having high GDP reporting confirmed cases faster than those with low GDP.
A study found that older children hospitalized with pandemic H1N1 influenza had more severe medical conditions than those with seasonal influenza. Vaccination is crucial for this age group and those with pre-existing conditions to prevent hospitalization.
Researchers at St. Jude Children's Research Hospital found that individuals who received the 1976 vaccine mounted a stronger immune response against both the 2009 pandemic H1N1 virus and a different H1N1 strain. The study suggests that routine vaccination against seasonal flu might confer broader-than-realized protection.
The intersection of foreign policy and global health interests can prioritize certain health concerns over others. Global health diplomacy is being used as a means to further foreign policy objectives, such as improving security or projecting power.
Scientists discovered that chicken antibodies from vaccinated hens can prevent H5N1 and H1N1 infections in mice, raising hope for an affordable and effective alternative to control influenza outbreaks.
Researchers use the GeoViz Toolkit to analyze disease statistics and identify trends in geographic patterns. This allows for better understanding of complex events like the spread of Swine flu.
Researchers analyzed vaccination data and found only 35 reports of GBS following 2009 H1N1 vaccination, a rate of 3.5 per 10 million people vaccinated. In contrast, the seasonal flu vaccination in 2009 reported 57 cases, an estimated rate of 7.3 per 10 million vaccinations.
Researchers in Canada investigated whether seasonal flu vaccination increased the risk of getting pandemic H1N1 flu. Four studies involving over 2,700 people found that prior vaccination was associated with a 68% increased likelihood of pH1N1 illness, but not with hospitalization.
Two people with compromised immune systems developed drug-resistant strains of the 2009 H1N1 virus after less than two weeks on therapy. Both patients showed clinical resistance to oseltamivir and peramivir, emphasizing the need for alternative treatment strategies.
Researchers found that surgical masks were as effective as respirators in preventing hospital staff from acquiring H1N1. The study suggests that a uniform policy of using surgical masks when in close contact with patients can protect healthcare workers from infection.
The Norwegian Influenza Study (NorFlu) aims to understand the effects of influenza in pregnancy on maternal health and childhood development. Pregnant women in Bergen and Oslo will participate in the study, providing a blood sample and completing a questionnaire.
Researchers found that pandemic influenza viruses from 1918 and 2009 share a structural detail that makes them susceptible to neutralization by the same antibodies. Vaccination with either virus can generate cross-reactive antibodies capable of neutralizing the other virus.
The Scripps Research Institute team solved the structure of the 'swine flu' virus, revealing similarities with earlier human flu viruses. This discovery helps explain why older individuals were less severely affected by the recent outbreak than younger ones.
A new study found that chest x-rays can predict which H1N1 patients are likely to become sicker. Abnormal findings in the periphery of both lungs were associated with poor clinical outcomes. The study's findings suggest that chest x-rays may help clinicians better identify high-risk patients who require close monitoring.
Infrared Thermal Detection Systems detected fever in patients with high accuracy, identifying patients with temperature above 100.0°F across all age ranges and genders.
A study found that household discussions about influenza prevention reduced the risk of secondary cases by 40%. Transmission was rapid, with half of cases occurring within three days and nearly 90% within one week.
A new study published in Pediatric Critical Care Medicine found that children with chronic illnesses are more likely to develop severe H1N1 infections. With careful management, pediatric ICUs can meet increased demands during a pandemic. Researchers also modeled PICU surge capacity and found it should be adequate with adaptable planning.
Research at Ohio State University suggests that pandemic H1N1 flu strains may become resistant to Tamiflu, the primary antiviral drug used to treat the disease. The study found that mutations in the neuraminidase protein of seasonal and pandemic H1N1 viruses drove the development of resistance to Tamiflu.
A Northwestern University professor explores making public policy with limited information, recommending the elimination of inferior options and application of decision criteria to avoid poor outcomes in issues like global warming and vaccination policies.
A Chilean hospital's early use of antiviral treatment and aggressive management improved outcomes for H1N1 patients, with virtually all receiving treatment within 48 hours. The hospital also implemented life support measures such as ECMO to further reduce severe cases and deaths.
A new study found that genetic interactions between avian H5N1 influenza and human seasonal influenza viruses can create hybrid strains with increased virulence. The researchers identified a key gene segment, PB2, which is responsible for the increased pathogenicity.
Research reveals human Chlamydia pneumoniae originated from an animal source, specifically amphibians like frogs, and has adapted to infect humans. The study's findings emphasize the need for improved diagnostic tests, precautions, and vaccine development to combat this respiratory disease.
Carlos Castillo-Chavez analyzes Mexico's response to the 2009 H1N1 outbreak, highlighting the impact of social distancing measures and diagnostic infrastructure on disease spread. His research aims to inform optimal public health policies for non-wealthy nations and address the limited access to antiviral drugs and vaccines.
A new study found that critically ill patients with H1N1 influenza do not need increased Tamiflu dosages, contrary to international guidelines. The study showed that the 75 mg twice daily dosage of Tamiflu was well absorbed in these patients.
A Canadian study analyzed 1479 hospital admissions for H1N1, finding that delays in seeking care increased the risk of death. Patients with underlying medical conditions and those over 20 years old were most susceptible to severe outcomes.
A new study predicts the impact and cost-effectiveness of different vaccination options for pandemic influenza, revealing that prioritizing high-risk individuals is likely very cost-effective. The model was applied to the 2009 H1N1 outbreak and accurately predicted when the epidemic would peak and who should be vaccinated.
According to a recent Harvard T.H. Chan School of Public Health poll, nearly half of Americans (44%) think the H1N1 flu outbreak is over, while concerns about getting sick have decreased. Meanwhile, most adults do not intend to get vaccinated, with 61% citing reasons such as safety risks and lack of perceived risk.
A targeted preventive approach using Tamiflu and strict hand hygiene measures contained the outbreak of H1N1 influenza among 171 campers. The plan, developed by Dr. David Kimberlin and implemented in 2009, successfully prevented illness in all campers, including those at high risk.
A targeted antiviral medication program, combined with aggressive hand sanitization and surface decontamination, was associated with containing the spread of H1N1 in a summer camp setting. The study found that the program reduced the attack rate of the virus from 1.8% to zero among campers.
The pandemic H1N1 influenza virus replicates efficiently in lung cells and infects conjunctiva, suggesting a potential route of transmission; however, it does not induce cytokine dysregulation like highly pathogenic avian flu viruses.
A Canadian Medical Association Journal study found that longer intervals between symptom onset and antiviral treatment were associated with more severe H1N1 disease necessitating ICU admission. People of First Nations ethnicity were also at a higher risk of severe H1N1 infection compared to other ethnic groups.
The BC Centre for Disease Control has launched a genomic surveillance project to study the evolution of the pandemic H1N1 flu virus in British Columbia. Researchers will compare the genetic sequences of BC's influenza viruses with those from other regions to understand how mass gatherings like the Olympics impact the virus' evolution.
A study of college students found that wearing face masks and practicing hand hygiene reduced influenza-like symptoms by 35-51%. The use of hand sanitizer did not add significant benefit, suggesting that mask-wearing alone is enough to limit the spread of flu.
A study found the proportion of children in high-risk areas infected with H1N1 during the first pandemic wave was 10 times higher than estimated from clinical surveillance. This suggests that children play a key role in transmission and are a target group for vaccination.
Scientists tested 2009 and 1918 H1N1 virus strains on chickens and ducks without causing disease or symptoms. The results suggest that birds played no role in the spread of these pandemic viruses.
Researchers at ACS' Organic Letters journal have created a more affordable version of the anti-flu drug Tamiflu by leveraging D-ribose, a naturally occurring sugar. The new process could significantly reduce production costs, making it easier to distribute the medication globally.
The updated childhood vaccine schedule recommends the H1N1 influenza vaccine for children over 6 months and prioritizes combination vaccines. The revised schedule also includes recommendations for human papillomavirus (HPV) and meningococcal vaccines, aiming to protect against cervical cancer and meningococcal disease.
A study of critically ill H1N1 children found that serious complications developed quickly and unpredictably, with great variations from patient to patient. The virus behaves variably in different patients, highlighting the need for rapid screening tests and preemptive antiviral medications.
A new study predicts that the H1N1 virus can spread quickly on planes, particularly in crowded economy classes. Researchers used mathematical modeling to estimate potential infections during long-haul flights and found that two to five infections could occur on a five-hour flight.
Scientists in Vienna have developed a new technique using insect cells to produce vaccines for H1N1 'swine flu', which can meet the demand of a global flu pandemic. This method is faster than traditional egg-based production and offers a safe alternative with reduced biosafety issues.
A new study published in the New England Journal of Medicine found that young people under 18 are more susceptible to catching swine flu from an infected person in their household. However, the risk of transmission does not vary by age, with household contacts over 50 being the least likely to get infected.
A study found a strong correlation between the presence of Streptococcus pneumoniae and increased risk for severe H1N1 pandemic influenza virus infections. The bacteria were present in most severe cases, with a 125-fold increased risk of severe disease among individuals aged 6-55.
Researchers at Medical College of Wisconsin develop rapid semi- and fully-automated multiplex real-time RT-PCR assays for detecting human H1N1, H3N2, and swine-origin H1N1 viruses. The tests can distinguish between influenza A, B, and RSV infections, reducing technician and assay time.
Brazilian researchers have identified three distinct lung damage patterns and found that underlying medical conditions significantly contribute to fatal outcomes. The study highlights the importance of monitoring patients with pre-existing conditions, as they are at a higher risk of developing severe H1N1 infections.
A new poll by Harvard T.H. Chan School of Public Health shows that three-quarters of parents who tried to get the H1N1 vaccine for their children were able to do so. However, more than a third of parents do not intend to get the vaccine due to safety concerns. Overall, six in ten parents have gotten or expect to get their children vacc...
A study published in JAMA found that a single dose of the H1N1 vaccine may provide sufficient protection for infants and children, reducing transmission of the virus. The researchers assessed the effectiveness and safety of two doses of the vaccine in healthy infants and children, aged six-months to less than 9 years, living in Australia.
Investigators at Burnham Institute for Medical Research identified 295 human cell factors that influenza A strains must harness to infect a cell. The team also found small molecule compounds that act on several of these factors and inhibit viral replication, pointing to new ways to treat flu.
Researchers have developed a comprehensive understanding of the interaction between H1N1 strains and human cells, revealing new targets for therapy and potential tools to speed vaccine production. The studies also identified key proteins involved in viral replication and host response.
A team of researchers has identified a human protein called IFITM3 that blocks the replication of H1N1 influenza virus and other viruses. The discovery could lead to the development of more effective antiviral drugs, including prophylactic drugs to slow influenza transmission.
Researchers from Tel Aviv University used bacterial decision-making to advise against automatic swine flu shot uptake. Bacteria communicate through chemical signals and consider risks before making decisions, suggesting a cautious approach for humans. They propose that only individuals with widespread contact should receive the vaccine.
Preliminary studies indicate that a single dose of H1N1 influenza vaccine provides sufficient protection for adults, while children under 9 years may require a two-dose vaccination schedule. The vaccine was found to be safe and acceptable in all age groups, with no serious adverse events reported.
A study analyzing hospitalized and outpatient patients found high levels of interleukin 17 in severe H1N1 cases, while low levels were seen in mild cases. The molecule's role in regulating white blood cells may hold the key to reducing inflammation and speeding up recovery.
Influenza is circulating in Africa, causing sporadic outbreaks and potentially severe epidemics due to inadequate surveillance. The authors argue that improved monitoring is needed to accurately assess the burden of influenza in tropical countries like Africa.
Researchers at Berkeley Lab have identified a new genetic mutation in the H1N1 flu virus that enables it to replicate in humans. The SR polymorphism mutation enhances polymerase activity and potentially pathogenesis of the virus in humans.
Researchers at Rice University and Baylor College of Medicine found a previously unrealized role of receptor-binding residues in host evasion, which could be a bottleneck for the virus. This discovery may lead to more efficient vaccine design not only for H1N1 but also for other strains of the flu.
A new RAND Corporation study found that US adults are not being vaccinated against the seasonal flu more often than last year. Despite increased public discussion about the importance of influenza vaccines, only 32% of all U.S. adults and 37% of those recommended to receive a flu vaccination had been inoculated by mid-November.
Researchers discovered that H1N1 virus retained the bird version of the polymerase but had an additional mutation that allowed it to function in human cells. This new combination increased the virus's efficiency in human cells and could potentially lead to increased virulence and pathogenicity.
Autopsies show that the 2009 H1N1 virus causes damage to both upper and lower respiratory tracts, with evidence of secondary bacterial infection present in over half of victims. The study also highlights the impact on younger people and the importance of identifying and treating severe infections.
A new study estimates the severity of the H1N1 flu during the autumn-winter flu season in the US, finding it may be less severe than initially thought. The study suggests that young children and non-elderly adults are at higher risk of complications from the illness.